Stephen Eason

Stephen Eason is the Vice President and Global Head of Regulatory Writing and Submissions at Novartis, where they lead a global team of over 150 associates involved in Medical Writing and Submission Management activities. Previously, they held several roles at Novartis, including Global Head of Regulatory Medical Writing and Group Head of Medical Writing, overseeing extensive teams across various global locations. With a D.Phil. in Immunology and Biochemistry from Ulster University, Stephen has a robust background in regulatory medical writing within the pharmaceutical industry, coupled with experience as a lecturer in Clinical Chemistry and Biochemistry at Nescot.